IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CSCIF

Balance Sheet

(in millions USD)
MetricQ4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents7.318.529.3313.7616.3920.0027.8029.5534.0238.7642.1946.5650.6153.8258.16--65.3068.0069.8773.37
Inventory1.311.761.822.462.693.313.060.060.07----------------------
Total Current Assets11.5013.8416.5020.3523.9828.2233.2131.2036.3741.9145.8950.7155.4958.6163.1767.1070.8272.4074.7377.56
Goodwill------------------------8.137.037.497.988.138.338.538.43
Total Non-current Assets*9.9310.0211.0610.7911.0915.5516.840.600.650.570.590.570.548.008.659.259.289.649.629.46
Total Assets21.4323.8627.5631.1435.0743.7750.0531.7937.0242.4946.4851.2856.0366.6171.8376.3480.1082.0484.3587.01
Total Current Liabilities3.613.985.537.067.228.179.905.254.544.234.086.437.045.976.415.677.774.784.554.95
Total Non-current Liabilities*13.9814.8014.9313.9414.6915.5913.9213.5714.2811.9813.3313.6413.2111.2211.1217.5219.3517.3418.4617.89
Total Liabilities17.5918.7820.4621.0021.9123.7623.8218.8218.8216.2117.4020.0720.2517.1917.5323.1927.1222.1223.0122.84
Retained Earnings(20.51)(19.05)(17.23)(14.65)(12.11)(5.16)1.53(375.26)(369.83)(362.09)(358.94)(356.50)(352.08)(338.66)(333.45)(334.51)(334.62)(327.71)(326.23)(323.22)
Total Stockholder Equity3.845.087.1010.1413.1620.0126.2312.9718.2026.2829.0831.2135.7849.4254.2953.1652.9959.9361.3564.17
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Total Revenue1.482.751.501.872.340.000.002.252.131.86(0.22)1.520.600.600.59
Cost of Revenue*0.861.781.060.911.52--------------------
Gross Profit0.620.970.440.960.82--------------------
Research & Development0.530.691.132.801.532.582.752.934.013.292.402.390.800.740.36
Selling, General & Admin1.651.652.932.993.043.511.792.032.312.061.781.561.231.651.26
Total Operating Expenses*2.943.334.067.254.576.114.555.106.345.584.494.332.422.711.90
Operating Income(2.32)(2.35)(3.62)(6.29)(3.75)(6.11)(4.55)(2.85)(4.21)(3.72)(4.72)(2.81)(1.82)(2.11)(1.32)
Pretax Income(1.82)(2.70)(3.65)(5.87)(1.90)(5.75)(4.14)(2.52)(4.25)(3.42)(4.22)(2.64)(1.70)(2.04)(1.57)
Tax Provision--0.00(0.41)(0.11)(0.47)----------(0.13)--(0.13)(0.13)(0.13)
Net Income(1.82)(2.70)(3.65)(5.75)(1.42)(5.75)(4.14)(2.52)(4.25)(3.42)(4.22)(2.64)(1.70)(2.04)(1.44)
Basic EPS(0.57)(0.85)(1.16)(1.85)(0.64)(4.74)(0.85)(0.52)(0.88)(0.70)(0.87)(0.02)(0.01)(0.02)(0.02)
Diluted EPS(0.57)(0.85)(1.16)(1.85)(0.64)(4.74)(0.85)(0.52)--(0.70)(0.87)(0.02)(0.01)(0.02)(0.02)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Operating Cash Flow(0.68)(4.45)(1.88)(7.78)(1.39)(4.29)(3.38)(4.29)(4.06)(3.94)(4.85)(1.46)(1.49)(3.63)(1.04)
Investing Cash Flow0.00(0.05)(0.61)0.0825.88-0.00(0.01)-0.00-0.00-0.00(0.04)(0.01)(0.02)-0.00(0.51)
Financing Cash Flow(0.08)(0.11)(0.20)(0.19)(0.13)(0.04)(0.03)(0.04)(0.04)(0.03)(0.03)(0.03)(0.03)0.0250.93
← Scroll for more columns →